airway | mecfa

MECFA Blog

Staphylococcus Aureus in CF Airways Change With Age, Antibiotic Use, Study Says

Different types of Staphylococcus aureus can be found persistently in the airways of cystic fibrosis (CF) patients, but this bacteria...

Lower airway infection prevalence changing in children with cystic fibrosis

The prevalence of lower airway infections with Pseudomonas aeruginosa, Staphylococcus aureus and Haemophilus influenzae among young...

New Intra-Nasal Imaging to Examine Airways in Cystic Fibrosis Patients

A simple, minimally invasive new tool for observing differences in the nasal airways of cystic fibrosis patients in vivo at a cellular...

Minimally Invasive Imaging Device Shows Changes in Nasal Airways, May Allow Earlier CF Diagnosis

A minimally invasive imaging device that generates high-resolution images of nasal airways, including the cilia and mucus, allows...

SNSP113 (Previously SYGN113)

SNSP113 is an inhaled therapy being developed by Synspira Therapeutics that aims to ease pulmonary infections, airway congestion, and...

Decreasing Acidity of Airway Liquid in Newborn CF Patients May Reduce Infection Risk, Study Suggests

Normalizing the acidity in the thin layer of liquid covering the airways of newborns with cystic fibrosis might make them more resistant...

New Test of Mucus Properties May Help with Coughing and Airway Clearance in CF

A new test was able to assess various properties of the mucus that accumulates in the lungs of people with cystic fibrosis and other...

Scientists Reveal New Cystic Fibrosis Treatments Work Best in Inflamed Airways

New UNC School of Medicine research led by Martina Gentzsch, PhD, and Carla Ribeiro, PhD, suggests that cystic fibrosis drugs used to...

Myoepithelial Cells Are Reserve Stem Cells For Lung Airway Repair

A new population of stem cells that appear to be important for regenerating the airway following severe injury has been identified by...

Airway Abnormality, Immunodeficiency Are Key Causes of Non-CF Bronchiectasis in Turkey, Study Finds

The most common causes of non-cystic fibrosis bronchiectasis in Turkish children are an airway abnormality called primary ciliary...

Disease Duration, Flare-ups Affect Mental Health of Non-CF Bronchiectasis Patients, Study Finds

VERTEX’S CF BLOCKBUSTER TRIKAFTA EFFECTIVE IN KIDS 6 TO 11 YEARS OF AGE

A case for improved carrier screening

Vertex to Seek Expanded FDA Approval for Trikafta After Positive Child Safety Data

Vertex’s Kaftrio approved for use in Europe and made accessible on the NHS

Age May Affect Outcomes in Lung Transplant Recipients With Cystic Fibrosis

CFF Funding Will Further ContraFect’s Research Into Alternative for Antibiotics

The search for molecular glue in targeted disease control

Vest Therapy Lowers Risk of Hospitalization in Non-CF Bronchiectasis, Study Says

Harvard is working with Boston hospitals to test existing cystic fibrosis drug to help coronavirus p